Product
Sequential treatment group
1 clinical trial
1 indication
Indication
Type 2 DiabetesClinical trial
Evaluation of Efficacy and Safety of Combination Therapy of Henagliflozin Proline, Retagliptin and Metformin Compared to Sequential Metformin Therapy in Newly Diagnosed Type 2 Diabetes PatientsStatus: Not yet recruiting, Estimated PCD: 2026-05-30